In this interview with TraceLink’s Dan Walles, VP Global Solutions following his presentation at FutureLink Munich conference, we discuss automated software validation and how drug companies can benefit from it.
Interview
Q. What’s the current state of play in the pharma industry when it comes to serialisation?